- Home
- ABEO vs KFS Comparison
ABEO vs KFS Comparison
Compare ABEO & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABEO | KFS |
|---|---|---|
| Founded | 1974 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.5M | 325.8M |
| IPO Year | 2005 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ABEO | KFS |
|---|---|---|
| Price | $5.53 | $10.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 918.3K | 40.8K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,998,000.00 | ★ $134,996,000.00 |
| Revenue This Year | $1,024.31 | N/A |
| Revenue Next Year | $145.42 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 258.18 | 23.42 |
| 52 Week Low | $4.00 | $9.84 |
| 52 Week High | $7.54 | $16.80 |
Technical Indicators
Market Signals| Indicator | ABEO | KFS |
|---|---|---|
| Relative Strength Index (RSI) | 51.58 | 43.54 |
| Support Level | $5.24 | $10.00 |
| Resistance Level | $5.64 | $12.06 |
| Average True Range (ATR) | 0.23 | 0.53 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 47.52 | 30.69 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The company generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.